When OS and EFS rates were compared between NB patients with YAP‐1 positive and negative tumors using a Log‐rank survival analysis, NB patients with YAP‐1 positive tumors were shown to have significantly lower EFS and OS rates (p < 0.001) (Fig. 3). This evidence concerns the gene YAP1 and neuroblastoma.